We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBRK icon
76
Rubrik
RBRK
$14.7B
$4.76M 0.34%
78,089
+22,573
+41% +$1.54M
ODD icon
77
ODDITY Tech
ODD
$784M
$4.74M 0.34%
109,518
+28,152
+35% +$1.25M
AMCR icon
78
Amcor
AMCR
$21.6B
$4.74M 0.34%
+97,642
New +$4.81M
QRVO icon
79
Qorvo
QRVO
$8.09B
$4.72M 0.34%
+65,166
New +$4.96M
VLTO icon
80
Veralto
VLTO
$24.2B
$4.68M 0.33%
48,047
-3,000
-6% -$299K
TGT icon
81
Target
TGT
$65.5B
$4.62M 0.33%
+44,300
New +$5.54M
CLS icon
82
Celestica
CLS
$40.3B
$4.59M 0.33%
58,181
-19,413
-25% -$2.06M
RUN icon
83
Sunrun
RUN
$2.3B
$4.57M 0.32%
779,310
+709,699
+1,020% +$5.85M
QTWO icon
84
Q2 Holdings
QTWO
$3.71B
$4.56M 0.32%
57,010
+53,500
+1,524% +$4.72M
VIK icon
85
Viking Holdings
VIK
$46.6B
$4.54M 0.32%
114,239
+16,400
+17% +$756K
PODD icon
86
Insulet
PODD
$11.6B
$4.54M 0.32%
17,290
MUSA icon
87
Murphy USA
MUSA
$11.1B
$4.5M 0.32%
+9,588
New +$4.55M
ELF icon
88
e.l.f. Beauty
ELF
$4.96B
$4.47M 0.32%
71,193
+62,678
+736% +$5.46M
FTI icon
89
TechnipFMC
FTI
$28.9B
$4.4M 0.31%
138,841
-2,116
-2% -$63.4K
ALKS icon
90
Alkermes
ALKS
$8.42B
$4.34M 0.31%
131,383
+27,436
+26% +$895K
KVYO icon
91
Klaviyo
KVYO
$5.65B
$4.33M 0.31%
142,992
+31,093
+28% +$1.25M
GLW icon
92
Corning
GLW
$108B
$4.3M 0.31%
94,000
-6
-0% -$296
APLS
93
DELISTED
Apellis Pharmaceuticals
APLS
$4.27M 0.3%
195,165
+57,471
+42% +$1.59M
MTB icon
94
M&T Bank
MTB
$36.6B
$4.21M 0.3%
23,556
-19,538
-45% -$3.71M
NTRA icon
95
Natera
NTRA
$36.1B
$4.21M 0.3%
29,765
-890
-3% -$143K
GVA icon
96
Granite Construction
GVA
$5.31B
$4.1M 0.29%
54,355
+41,317
+317% +$3.45M
DVAX
97
DELISTED
Dynavax Technologies
DVAX
$4.08M 0.29%
314,861
-4
-0% -$53
ESLT icon
98
Elbit Systems
ESLT
$38.4B
$4.08M 0.29%
10,634
+3,130
+42% +$1.01M
MYRG icon
99
MYR Group
MYRG
$5.31B
$4.08M 0.29%
36,041
+9,661
+37% +$1.28M
PEN icon
100
Penumbra
PEN
$12.6B
$4.03M 0.29%
15,076
+3,546
+31% +$959K

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.